The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, X. K.
Right arrow Articles by Gilkeson, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, X. K.
Right arrow Articles by Gilkeson, G.
The Journal of Immunology, 2004, 173: 6481-6489.
Copyright © 2004 by The American Association of Immunologists

Decreased Expression of the Ets Family Transcription Factor Fli-1 Markedly Prolongs Survival and Significantly Reduces Renal Disease in MRL/lpr Mice1

Xian K. Zhang2,*, Sarah Gallant*, Ivan Molano*, Omar M. Moussa{dagger}, Phillip Ruiz{ddagger}, Demetri D. Spyropoulos{dagger}, Dennis K. Watson{dagger} and Gary Gilkeson*

* Department of Medicine, Division of Rheumatology and Immunology, Medical Research Service, Ralph H. Johnson Veterans Affairs Medical Center, and {dagger} Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC 29425; and {ddagger} University of Miami School of Medicine, Miami, FL 33136

Increased Fli-1 mRNA is present in PBLs from systemic lupus erythematosus patients, and transgenic overexpression of Fli-1 in normal mice leads to a lupus-like disease. We report in this study that MRL/lpr mice, an animal model of systemic lupus erythematosus, have increased splenic expression of Fli-1 protein compared with BALB/c mice. Using mice with targeted gene disruption, we examined the effect of reduced Fli-1 expression on disease development in MRL/lpr mice. Complete knockout of Fli-1 is lethal in utero. Fli-1 protein expression in heterozygous MRL/lpr (Fli-1+/–) mice was reduced by 50% compared with wild-type MRL/lpr (Fli-1+/+) mice. Fli-1+/– MRL/lpr mice had significantly decreased serum levels of total IgG and anti-dsDNA Abs as disease progressed. Fli-1+/– MRL/lpr mice had significantly increased splenic CD8+ and naive T cells compared with Fli-1+/+ MRL/lpr mice. Both in vivo and in vitro production of MCP-1 were significantly decreased in Fli-1+/– MRL/lpr mice. The Fli-1+/– mice had markedly decreased proteinuria and significantly lower pathologic renal scores. At 48 wk of age, survival was significantly increased in the Fli-1+/– MRL/lpr mice, as 100% of Fli-1+/– MRL/lpr mice were alive, in contrast to only 27% of Fli-1+/+ mice. These findings indicate that Fli-1 expression is important in lupus-like disease development, and that modulation of Fli-1 expression profoundly decreases renal disease and improves survival in MRL/lpr mice.




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
J. Elkareh, S. M. Periyasamy, A. Shidyak, S. Vetteth, J. Schroeder, V. Raju, I. M. Hariri, N. El-Okdi, S. Gupta, L. Fedorova, et al.
Marinobufagenin induces increases in procollagen expression in a process involving protein kinase C and Fli-1: implications for uremic cardiomyopathy
Am J Physiol Renal Physiol, May 1, 2009; 296(5): F1219 - F1226.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X. K. Zhang, O. Moussa, A. LaRue, S. Bradshaw, I. Molano, D. D. Spyropoulos, G. S. Gilkeson, and D. K. Watson
The Transcription Factor Fli-1 Modulates Marginal Zone and Follicular B Cell Development in Mice
J. Immunol., August 1, 2008; 181(3): 1644 - 1654.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
X. K. Zhang and D. K. Watson
The FLI-1 Transcription Factor Is a Short-Lived Phosphoprotein in T Cells
J. Biochem., March 1, 2005; 137(3): 297 - 302.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.